WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

SYNTHESIS, CHARACTERIZATION AND PHARMACOLOGICAL EVALUATIONS OF SUBSTITUTED QUINAZOLIN-4-(3H)-ONE DERIVATIVE AS NOVEL ANTICONVULSANT AGENTS

Meenu Chaudhary*, Praveen Chaudhary

ABSTRACT

Purpose: To synthesize and evaluate the anticonvulsant activity of substituted Quinazolin-4(3H)-one derivative. Methods: In the present study, total 19 derivatives of two series of substituted Quinazolin-4(3H)-one have been synthesized and elucidated on the basis of analytical and spectral studies such as IR, 1HNMR, and Mass spectroscopy. The preliminary evaluation of these 19 compounds for anti-inflammatory, anticonvulsant, diuretic, antihypertensive and antitubercular activities indicated some of them exhibit moderate to significant activity compared to control group. Further, on the basis of their SAR studies, it has been revealed that substitution at 2, 3 position of Quinazolin-4(3H)-one derivatives may confer various pharmacological activities such as antitumor, anti-HIV, anti-inflammatory, antibacterial and antidepressant etc. Result: out of nineteen synthesized compounds, only four synthesized compounds KA-3, KB-2, KD-1 and IA-1 have shown significant anticonvulsant activity with 90% recovery against MES-induced convulsions acting as GABAA receptor agonist. Conclusion: Among these four compounds, KD-1 and IA-1 has shown most and equieffective activity comparable to standard drug Phenytoin.

Keywords: Quinazolin-4-(3H)-one derivative, SAR study, MES, anticonvulsant activity.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More